CRISPR Therapeutics AG ($CRSP) Stock Forecast: Up 5.1% Today

What is CRISPR Therapeutics AG?

CRISPR Therapeutics AG (CRSP) operates in the biotechnology sector with a focus on developing transformative gene-based medicines. The overall market sentiment for CRSP today was bullish.

Why is CRISPR Therapeutics AG going up?

CRSP stock is up 5.1% on Jun 30, 2025 15:10

• CRISPR Therapeutics AG (CRSP) saw a significant bullish movement today, closing at $47.66, up 1.88% from the previous trading session.
• The stock outperformed the market, finishing at $46.78, reflecting a +2.7% change from the day before.
• The positive momentum may be linked to increasing investor confidence in CRISPR technology and its potential applications in gene-based medicine.
• The company's recent progress in its research and development pipeline could also be influencing the positive sentiment surrounding the stock.

CRSP Price Chart

CRSP Technical Analysis

CRSP News

CRISPR Therapeutics AG ( CRSP ) Stock Moves 1.88%: What You Should Know

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $47.66, moving +1.88% from the previous trading session.

https://www.zacks.com/stock/news/2554124/crispr-therapeutics-ag-crsp-stock-moves-188-what-you-should-know

CRISPR Therapeutics AG ( CRSP ) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $46.78, marking a +2.7% move from the previous day.

https://www.zacks.com/stock/news/2547868/crispr-therapeutics-ag-crsp-surpasses-market-returns-some-facts-worth-knowing

Trending Today

Sui ($SUI) Crypto Forecast: Down 5.1% Today

Ethena ($ENA) Crypto Forecast: Down 5.2% Today

Pepe ($PEPE) Crypto Forecast: Down 5.1% Today

Cardano ($ADA) Crypto Forecast: Up 5.2% Today

XRP ($XRP) Crypto Forecast: Up 6.2% Today

Apple Inc. ($AAPL) Stock Forecast: Up 2.3% Today

Robinhood Inc. ($HOOD) Stock Forecast: Up 6.7% Today

MicroStrategy ($MSTR) Stock Forecast: Up 5.1% Today

Plug Power Inc. ($PLUG) Stock Forecast: Up 17.8% Today

Sunrun Inc. ($RUN) Stock Forecast: Up 7.1% Today

CRISPR Therapeutics AG Price History

11.05.2025 - CRSP Stock was down 5.2%

• The bearish movement in CRSP stock today can be attributed to the following factors:
• Despite the overall bullish market sentiment, CRSP experienced a significant drop, indicating potential profit-taking by investors.
• The stock may have been overbought recently, leading to a correction in its price.
• Challenges in regulatory issues or setbacks in the development of CRISPR-based therapies could have spooked investors, causing a sell-off in the stock.
• Technical indicators may have signaled a bearish trend, prompting traders to sell their positions in CRSP.

21.03.2025 - CRSP Stock was up 5.4%

• Factors contributing to the bullish movement in CRSP stock:
• Despite a slight slide in the stock price, the overall market was rising, indicating positive investor sentiment.
• Investors may be optimistic about CRISPR Therapeutics' potential in the field of gene editing technologies.
• The slight decrease in stock price could be a minor correction after previous gains, rather than a significant bearish trend.
• Traders might be reacting to the broader market movements rather than company-specific news, leading to the bullish momentum in CRSP stock.

05.01.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics AG (CRSP) exhibited strong bullish movement today, surpassing the overall stock market performance.
• Investor confidence in CRISPR Therapeutics AG (CRSP) might have been bolstered by Cathie Wood's Ark Invest's positioning, influencing the positive stock movement.
• The company's emphasis on innovative gene-based therapies could have contributed to the optimistic investor sentiment.
• The bullish movement in CRSP stock today may be attributed to the favorable market sentiment, strategic investments by influential entities like Ark Invest, and the promising future of CRISPR technology.

30.05.2025 - CRSP Stock was up 5.1%

• CRISPR Therapeutics AG (CRSP) saw a significant bullish movement today, closing at $47.66, up 1.88% from the previous trading session.
• The stock outperformed the market, finishing at $46.78, reflecting a +2.7% change from the day before.
• The positive momentum may be linked to increasing investor confidence in CRISPR technology and its potential applications in gene-based medicine.
• The company's recent progress in its research and development pipeline could also be influencing the positive sentiment surrounding the stock.

07.03.2025 - CRSP Stock was up 5.1%

• Recent significant trades involving CRISPR Therapeutics AG (CRSP) by Ark Invest could have influenced investor confidence in the stock.
• An upcoming presentation at the 24th Annual Needham Virtual Healthcare Conference may have sparked positive anticipation and interest in the company's future.
• Favorable market sentiment toward innovative biopharmaceutical firms like CRISPR Therapeutics AG likely played a role in the stock's bullish movement, especially given ongoing advancements in gene-based medicine research.

26.02.2025 - CRSP Stock was down 5.4%

• Despite closing slightly higher in one session, the overall trend for CRSP has been negative, with a notable decline of -1.84%.
• The bearish movement could be attributed to profit-taking by investors after a period of growth or concerns about the company's pipeline or financial performance.
• It's important for investors to monitor any upcoming developments or announcements from CRISPR Therapeutics AG that could potentially reverse the current downward trend.

07.04.2025 - CRSP Stock was down 5.6%

• The company reported a wider-than-expected first-quarter loss and revenues that missed estimates, resulting in a 12% decline in the stock price.
• Despite a slight advance in the most recent trading session, CRSP underperformed the overall market, revealing weakness in the stock.
• The disappointing Q1 earnings and sales figures are likely key factors in the bearish movement of CRSP's stock price today.
• Investors may have concerns about the company's financial performance and future growth prospects, prompting a sell-off of CRSP shares.

11.03.2025 - CRSP Stock was up 6.3%

• Despite a slight dip in the stock price, CRSP had a strong bullish movement overall for the day.
• Cathie Wood's Ark Invest loading up on CRSP shares could have contributed to the bullish momentum, signaling confidence in the company's future prospects.
• The market might be reacting positively to the potential of CRISPR Therapeutics AG's gene-editing technology in developing groundbreaking treatments, driving investor optimism and pushing the stock price higher.
• Overall, the bullish movement in CRSP could be attributed to both positive market sentiment towards the biotech sector and specific investor interest in the company's innovative approach to genetic medicine.

14.01.2025 - CRSP Stock was up 16.6%

• The bullish movement in CRSP stock today is linked to positive Q4 earnings and revenue surpassing estimates, indicating strong financial performance and market confidence in the company's innovative gene therapy solutions.
• An analyst upgrade from Telsey Advisory Group may have also contributed to the positive sentiment, showing increased optimism and potential future growth prospects for CRISPR Therapeutics.
• The successful commercial launch of Casgevy, the first CRISPR-based gene therapy, further strengthens investor confidence in CRSP's technological advancements and market potential, leading to an increase in the stock price.

06.04.2025 - CRSP Stock was down 5.7%

• Despite the overall market performing well, CRSP underperformed.
• The slight increase in stock price from the previous trading session was not enough to offset the bearish trend.
• Potential factors such as negative news, profit-taking, or market sentiment towards the biotech sector could have contributed to the bearish movement.
• Investors might be cautious about the company's future prospects or regulatory challenges in the gene editing industry.

12.01.2025 - CRSP Stock was up 8.1%

• Strong Q4 earnings and revenues were reported by CRSP, surpassing estimates.
• The successful commercial launch of Casgevy, the first CRISPR-based gene therapy, contributed to the bullish movement.
• Investor confidence in CRSP's innovative gene therapy solutions likely drove the stock price higher.

24.05.2025 - CRSP Stock was up 5.2%

• CRSP stock price increased by 2.87% despite a market slip.
• The bullish movement could be attributed to positive news or developments related to CRISPR Therapeutics AG.
• Investors may be optimistic about the company's future prospects or recent advancements in gene editing technology.
• The resilience of CRSP's stock price in the face of a market slip indicates strong investor confidence in the company's potential growth.